51
Participants
Start Date
November 21, 2017
Primary Completion Date
June 25, 2021
Study Completion Date
December 15, 2021
Golimumab (Optimization)
"Increase dose of golimumab.~* For patients treated at 50 mg will be performed, dose will be intensified at 100 mg every four weeks.~* For patients treated at 100 mg will be performed, dose will be intensified at 100 mg every two weeks while four weeks."
Rectosigmoidoscopy
Rectosigmoidoscopy will be realized for calculated Mayo score
Blood samples
Blood samples will be collected for analysis the concentration of golimumab and antibodies to golimumab (ADAb) in the blood
Chu Saint Etienne, Saint-Etienne
CHU Amiens-Picardie, Amiens
CHU Lyon Sud, Lyon
CHU Montpellier - St Eloi, Montpellier
CHU Nice, Nice
Merck Sharp & Dohme LLC
INDUSTRY
Centre Hospitalier Universitaire de Saint Etienne
OTHER